ProQR Therapeutics Names Hom as CFO, Lopez Lopez as Chief Medical Officer

Dow Jones

04-14

By Robb M. Stewart

ProQR Therapeutics has turned to a new chief financial officer and fresh chief medical officer to support the next phase of growth for the RNA therapies developer.

The Netherlands-based, Nasdaq-listed company said Monday it appointed Dennis Hom as finance chief and Cristina Lopez Lopez as chief medical officer to support the advancement of its Axiomer platform technology and pipeline of RNA editing programs as it enters the clinical stage.

Chief Financial Officer Jurriaan Dekkers and Chief Corporate Development Officer Rene Beukema will step down from their roles.

Hom most recently was CFO and head of corporate development at Sagimet Biosciences. Lopez most recently she served as global head of neurodegeneration at Johnson & Johnson.

Write to Robb M. Stewart at robb.stewart@wsj.com

(END) Dow Jones Newswires

April 14, 2025 07:44 ET (11:44 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2527159463"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2527159463\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2527159463?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-14 19:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2527159463","market":"hk","top_or_hot":-1,"title":"ProQR Therapeutics Names Hom as CFO, Lopez Lopez as Chief Medical Officer","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Robb M. Stewart \n</p>\n<pre>\n \n</pre>\n<p>\n  ProQR <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> has turned to a new chief financial officer and fresh chief medical officer to support the next phase of growth for the RNA therapies developer. \n</p>\n<p>\n  The Netherlands-based, Nasdaq-listed company said Monday it appointed Dennis Hom as finance chief and Cristina Lopez Lopez as chief medical officer to support the advancement of its Axiomer platform technology and pipeline of RNA editing programs as it enters the clinical stage. \n</p>\n<p>\n  Chief Financial Officer Jurriaan Dekkers and Chief Corporate Development Officer Rene Beukema will step down from their roles. \n</p>\n<p>\n  Hom most recently was CFO and head of corporate development at Sagimet Biosciences. Lopez most recently she served as global head of neurodegeneration at Johnson &amp; Johnson. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Robb M. Stewart at robb.stewart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 14, 2025 07:44 ET (11:44 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ProQR Therapeutics Names Hom as CFO, Lopez Lopez as Chief Medical Officer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nProQR Therapeutics Names Hom as CFO, Lopez Lopez as Chief Medical Officer\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-04-14 19:44</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Robb M. Stewart \n</p>\n<pre>\n \n</pre>\n<p>\n  ProQR <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> has turned to a new chief financial officer and fresh chief medical officer to support the next phase of growth for the RNA therapies developer. \n</p>\n<p>\n  The Netherlands-based, Nasdaq-listed company said Monday it appointed Dennis Hom as finance chief and Cristina Lopez Lopez as chief medical officer to support the advancement of its Axiomer platform technology and pipeline of RNA editing programs as it enters the clinical stage. \n</p>\n<p>\n  Chief Financial Officer Jurriaan Dekkers and Chief Corporate Development Officer Rene Beukema will step down from their roles. \n</p>\n<p>\n  Hom most recently was CFO and head of corporate development at Sagimet Biosciences. Lopez most recently she served as global head of neurodegeneration at Johnson &amp; Johnson. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Robb M. Stewart at robb.stewart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 14, 2025 07:44 ET (11:44 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"製藥","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2527159463","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2527159463","pubTimestamp":1744631040,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"ProQR Therapeutics has turned to a new chief financial officer and fresh chief medical officer to support the next phase of growth for the RNA therapies developer.The Netherlands-based, Nasdaq-listed company said Monday it appointed Dennis Hom as finance chief and Cristina Lopez Lopez as chief medical officer to support the advancement of its Axiomer platform technology and pipeline of RNA editing programs as it enters the clinical stage.Chief Financial Officer Jurriaan Dekkers and Chief Corporate Development Officer Rene Beukema will step down from their roles.Hom most recently was CFO and head of corporate development at Sagimet Biosciences. Lopez most recently she served as global head of neurodegeneration at Johnson & Johnson.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","BK4139":"生物科技","PRQR":"ProQR Therapeutics N.V.","LENZ":"Therapeutics"},"translate_title":"ProQR Therapeutics任命Hom为首席财务官，Lopez Lopez为首席医疗官","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"PRQR":0.9},"content_text":"By Robb M. Stewart \n\n\n \n\n\n  ProQR Therapeutics has turned to a new chief financial officer and fresh chief medical officer to support the next phase of growth for the RNA therapies developer. \n\n\n  The Netherlands-based, Nasdaq-listed company said Monday it appointed Dennis Hom as finance chief and Cristina Lopez Lopez as chief medical officer to support the advancement of its Axiomer platform technology and pipeline of RNA editing programs as it enters the clinical stage. \n\n\n  Chief Financial Officer Jurriaan Dekkers and Chief Corporate Development Officer Rene Beukema will step down from their roles. \n\n\n  Hom most recently was CFO and head of corporate development at Sagimet Biosciences. Lopez most recently she served as global head of neurodegeneration at Johnson & Johnson. \n\n\n \n\n\n  Write to Robb M. Stewart at robb.stewart@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 14, 2025 07:44 ET (11:44 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}